Research study on a new treatment for healthy volunteers
Treatments studied
This study tests an investigational treatment in healthy volunteers to see how safe it is and how the body processes it. It may help in developing a new medicine.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be a healthy adult who can give informed consent.
- You must be fluent in English to complete study procedures.
- You must not have significant medical or psychiatric conditions.
- You must have a normal heart rhythm test (ECG) at screening.
- You must be willing to stop certain medications that could interfere with the study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how a single dose of psilocybin (the active ingredient in magic mushrooms) affects brain structure in healthy older adults. You'll receive the drug in a safe setting and have brain scans before and after to see if it promotes positive changes.
This trial tests dietary supplements and other treatments aimed at slowing the effects of aging. It is looking for generally healthy adults who are not taking immune-altering medications or other conflicting therapies.
This research tests whether psilocybin (a psychoactive compound from certain mushrooms) is safe and well-tolerated in healthy people aged 65–85. Researchers want to understand how older adults respond to this substance and whether it could be useful for future treatments.
This study tests how psilocybin, a psychedelic substance, affects the brain and body in healthy volunteers. It aims to find biological and mental changes that could help future therapies.
This study tests whether a single dose of psilocybin (a psychedelic compound) can help people update their beliefs and gain new insights. It's for healthy adults with some prior psychedelic experience, and it's a small pilot study at Brown University.
This trial tests how the setting and context affect the experience of psilocybin, a psychedelic drug. It aims to understand how the environment influences the effects in healthy adults.
Hear when a new Longevity trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.